Crossmark

Investigation of potential inhibitor properties of violacein against HIV-1 RT and CoV-2 Spike RBD:ACE-2

Crossref DOI link: https://doi.org/10.1007/s11274-022-03350-0

Published Online: 2022-07-14

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dogancı, Merve Ayse https://orcid.org/0000-0003-3228-7029
Ay Sal, Fulya https://orcid.org/0000-0002-0216-336X
Guler, Halil Ibrahim https://orcid.org/0000-0002-7261-6790
Katı, Hatice https://orcid.org/0000-0002-2053-3168
Ceylan, Esma https://orcid.org/0000-0002-5559-8869
Belduz, Ali Osman https://orcid.org/0000-0003-2240-7568
Bozdal, Gozde https://orcid.org/0000-0003-1248-7912
Yaylı, Nurettin https://orcid.org/0000-0003-4174-3014
Canakcı, Sabriye https://orcid.org/0000-0003-0132-7198
License Information

Text and Data Mining valid from 2022-07-14

Version of Record valid from 2022-07-14
More Information

Article History

Received: 29 April 2022

Accepted: 28 June 2022

First Online: 14 July 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: No ethical approval is required.